Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Plus Therapeutics, Inc. (PSTV) had Normalized Income after Taxes of $-4.42M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.40M |
|
$-4.42M |
|
-- |
|
$1.40M |
|
$5.88M |
|
$-4.48M |
|
$0.06M |
|
$-4.42M |
|
$-4.42M |
|
$-4.42M |
|
$-4.42M |
|
$-4.42M |
|
|
Normalized Income after Taxes |
$-4.42M |
$-4.48M |
|
$-4.41M |
|
107.43M |
|
107.43M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$17.59M |
|
$0.27M |
|
$1.08M |
|
$18.67M |
|
$13.62M |
|
-- |
|
-- |
|
$13.62M |
|
$5.05M |
|
$4.31M |
|
$5.05M |
|
131.61M |
|
| Cash Flow Statement Financials | |
$-14.52M |
|
$0.22M |
|
$27.51M |
|
$0.08M |
|
$13.29M |
|
$13.21M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-320.83% |
|
-320.83% |
|
-- |
|
-316.61% |
|
-316.61% |
|
$-14.53M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-87.52% |
|
-102.67% |
|
-23.69% |
|
-87.51% |
|
$0.04 |
|
$-0.14 |
|
$-0.14 |
|